Docmacy Pharmaworld Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.50 M
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -46.77%
- Profit Growth -14193.82%
- Ebitda 76.90%
- Net Worth -44.09%
- Total Assets -55.57%
About Docmacy Pharmaworld
Docmacy Pharmaworld Private Limited (DPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 11 July 2020 (Four years and six months 24 days old ). Its registered office is in Vadodara, Gujarat, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Company Details
-
Location
Vadodara, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24290GJ2020PTC114539
-
Company No.
114539
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
11 Jul 2020
-
Date of AGM
27 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Docmacy Pharmaworld?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chirag Vadgama
|
Director | 11-Jul-2020 | Current |
|
Vatsal Pandya
|
Director | 11-Jul-2020 | Current |
Financial Performance of Docmacy Pharmaworld.
Docmacy Pharmaworld Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 46.77% decrease. The company also saw a substantial fall in profitability, with a 14193.82% decrease in profit. The company's net worth observed a substantial decline by a decrease of 44.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Docmacy Pharmaworld?
Unlock access to Docmacy Pharmaworld's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Webrefine Technology LlpVatsal Pandya is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Docmacy Pharmaworld?
Docmacy Pharmaworld has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Docmacy Pharmaworld, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Docmacy Pharmaworld's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.